• In late June 2026, CareTrust REIT, Inc. (NYSE: CTRE) was removed from multiple Russell growth and small-cap indexes, shortly after its Board reaffirmed a quarterly cash dividend of US$0.39 per share payable in mid-July to shareholders of record on June 30, 2026.
• This combination of index deletions and steady dividend payments highlights a tension between potential index-related selling pressure and the company’s ongoing income profile for shareholders.
• Against this backdrop, we will examine how CareTrust’s broad removal from Russell growth benchmarks may shape its existing investment narrative.

Outshine the giants: these 15 early-stage AI stocks could fund your retirement.

CareTrust REIT Investment Narrative Recap

To own CareTrust REIT today, you need to believe in its ability to keep converting a growing healthcare-focused property portfolio into reliable rental cash flows and dividends. The recent removal from several Russell growth and small-cap indexes may create some short term technical selling pressure, but it does not directly change the fundamental catalyst around portfolio expansion, nor the key risk of execution missteps as the company scales and integrates new markets.

The reaffirmed quarterly dividend of US$0.39 per share, payable in mid July 2026, is the most relevant recent announcement in this context, because it underscores management’s current income focus even as index-related flows may be turning more negative. For investors, this tension between cash returns and potential index selling sits alongside the larger catalyst of deploying a sizeable investment pipeline into skilled nursing, senior housing and U.K. care homes at attractive yields.

Yet despite the steady dividend, investors should be aware that rising G&A costs and integration complexity could...

CareTrust REIT's narrative projects $970.3 million revenue and $494.9 million earnings by 2029. This requires 22.9% yearly revenue growth and an earnings increase of about $159.9 million from $335.0 million today.

Uncover how CareTrust REIT's forecasts yield a $45.50 fair value, a 13% upside to its current price.

Exploring Other Perspectives

Five fair value estimates from the Simply Wall St Community span roughly US$26 to US$96 per share, showing how far apart individual views can be. When you set that against the current focus on rapid portfolio expansion and integration risk, it underlines why it can help to review several independent perspectives before forming your own view on CareTrust’s longer term performance.

Explore 5 other fair value estimates on CareTrust REIT - why the stock might be worth 35% less than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your CareTrust REIT research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free CareTrust REIT research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CareTrust REIT's overall financial health at a glance.

Interested In Other Possibilities?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Find 44 companies with promising cash flow potential yet trading below their fair value.
• The future of work is here. Discover the 29 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Rare earth metals are the new gold rush. Find out which 30 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.